These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 30955830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T, Karuppannan AK, Halbur PG, Calvert JG, Nitzel GP, Matzinger SR, Meng XJ.
    Vaccine; 2020 Feb 18; 38(8):1975-1981. PubMed ID: 31974016
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T, Xiao CT, Halbur PG, Gerber PF, Matzinger SR, Meng XJ.
    Vaccine; 2017 Jan 05; 35(2):248-254. PubMed ID: 27919634
    [Abstract] [Full Text] [Related]

  • 7. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T, Castro AMMG, Karuppanan AK, Gauger PC, Halbur PG, Matzinger SR, Meng XJ.
    Vaccine; 2019 Oct 16; 37(44):6688-6695. PubMed ID: 31537445
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ, Fu YJ, Huang LP, Wang YP, Wei YW, Wu HL, Liu CM.
    Vaccine; 2015 Jul 17; 33(31):3752-7. PubMed ID: 26051516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J.
    Vet Immunol Immunopathol; 2012 Nov 15; 150(1-2):128-32. PubMed ID: 23010221
    [Abstract] [Full Text] [Related]

  • 16. Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea.
    Kang SJ, Kang H, You SH, Lee HJ, Lee N, Hyun BH, Cha SH.
    BMC Vet Res; 2020 Sep 14; 16(1):334. PubMed ID: 32928247
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C, Jeong J, Choi K, Chae C.
    Vaccine; 2016 Jan 04; 34(2):270-275. PubMed ID: 26626212
    [Abstract] [Full Text] [Related]

  • 18. [Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].
    Eddicks M, Szikora F, Walhöfer N, Sauter Louis C, Reese S, Banholzer E, Reiner G, Sutter G, Ritzmann M, Fux R.
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2017 Apr 19; 45(2):90-97. PubMed ID: 28327779
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of cross-immunity among major porcine circovirus type 2 genotypes by infection with PCV2b and PCV2d circulating strains.
    Yu C, Cao M, Wei Y, Liu J, Zhang H, Liu C, Feng L, Huang L.
    Vet Microbiol; 2023 Aug 19; 283():109796. PubMed ID: 37285792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.